急性秋水仙碱中毒患者的救治经验分享

来源 :中华危重病急救医学 | 被引量 : 0次 | 上传用户:cyf454545
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
秋水仙碱又称秋水仙素,临床上主要用于治疗急性痛风发作、慢性痛风急性发作等疾病,但该药毒性大(剧毒类),且治疗剂量与中毒剂量非常接近,中毒后无特效解毒药物,患者早期临床表现缺乏特异性,给临床诊断和治疗带来一定的难度与挑战,无形中增加了药物中毒致死的概率。到目前为止,秋水仙碱中毒病例均以散发报道,2020年9月1日松桃苗族自治县人民医院收治1例急性秋水仙碱中毒患者,是目前为止权威医学期刊能检索到中毒时间最长的1例,经治疗患者于9月29日痊愈出院,本文报告了该病例的诊治体会。“,”Colchicine is mainly used in the treatment of acute gout attack, acute attack of chronic gout and other diseases in clinic. But the drug has high toxicity (highly toxic), the therapeutic dose is very close to the toxic dose, and there is no special effect after poisoning drug detoxification. The clinical manifestations of early patients after poisoning are not specific, which brings some difficulties and challenges in clinical diagnosis and treatment, and virtually increases the probability of death from drug poisoning. The drug poisoning is still sporadic reports. On September 1, 2020, a patient with acute colchicine poisoning was admitted to People's Hospital of Songtao Miao Autonomous County. This patient is the one with the longest poisoning time that can be retrieved by authoritative medical journals. After treatment, the patient was cured and discharged. This article reported the experience of diagnosis and treatment.
其他文献
会议
会议
会议
会议
  Non-inferiority of a diagnostic test to the standard or the optimum test is a common issue in medical research.In this paper, we consider the probl
会议
会议
目的:探讨无义突变的人凝血因子Ⅸ小基因稳定细胞株发生选择性剪接的分子机制.方法:将人凝血因子Ⅸ小基因(Mini-hF9)及其无义突变体分别转染哺乳动物细胞HeLa,经G418抗性筛选
目的 分析尿常规与尿微量白蛋白(MAU)检测在糖尿病(DM)早期肾损伤诊断中的应用价值.方法 选取2019年3~10月在本院就诊的53例DM早期肾损伤患者作为观察组,另选取同期于本院接受
会议
目的 研究高频超声联合低频超声在急性阑尾炎诊断中应用研究.方法 105例急性阑尾炎患者,以随机数字表法分为观察组(55例)和对照组(50例).对照组采用低频超声检查,观察组采用